Legal Representation
Attorney
Mark J. Liss
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 20, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| May 20, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Feb 3, 2024 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Feb 3, 2024 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Feb 3, 2024 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jan 12, 2024 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jun 8, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 8, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 8, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 10, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 10, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 10, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 7, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 4, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 4, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 4, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 16, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 16, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; injectable dermal fillers; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; vaccines; medicated lotions for skin, hair, sunburn, face, body; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain
Classification
International Classes
005